Skip to main content
. 2019 Sep 16;13:1557–1567. doi: 10.2147/PPA.S225561

Table 1.

Sociodemographic and baseline information of participants (N=321)

Characteristics Mean ± SD or N (%)
Region Seoul 112 (34.9)
Gyeong-gi 173 (53.9)
Others 36 (11.2)
Age (years) 55.6±10.2
Age at diagnosis 52.1±10.0
Years since diagnosis Less than 3 years 161 (50.2)
3–5 years 88 (27.4)
6–10 years 44 (13.7)
More than 10 years 28 (8.7)
Breast cancer Stage 0 (DCIS) 7 (2.4)
1 127 (43.6)
2 109 (37.5)
3 40 (13.7)
4 8 (2.7)
Type HR (positive) 75 (26.3)
HER2 (positive) 33 (12.1)
Current treatment Numbers Single 178 (55.5)
Double 23 (7.2)
Triple 11 (3.4)
Type Hormonal therapy 137 (42.7)
Chemotherapy 80 (24.9)
Radiation therapy 38 (11.8)
Past treatment Surgery Partial-mastectomy 137 (43.4)
Mastectomy 47 (14.9)
Hormonal therapy 69 (21.5)
Chemotherapy 129 (40.2)
Radiation therapy 143 (44.5)
Illness perception Negative 68.94±15.11
Positive 57.66±7.77
Sense of well-being Physical 20.33±6.47
Social 17.41±6.92
Emotional 15.59±5.31
Functional 16.41±6.23
Breast cancer specific 22.53±6.29
Total 92.28±21.61
Perceived social support Family 20.63±4.80
Friends 19.92±5.19
Important Others 20.86±4.61
Total 61.42±13.95

Abbreviations: DCIS, ductal carcinoma in situ; HR, hormone receptor; HER2, human epidermal growth factor receptor 2; SD, standard deviation.